I think Pharmaxis changing their name is a step in the right direction as I think Pharmaxis leaves a bad taste with many investors.
I really want to believe in Pxs/ syn however my belief in them is slowly being chipped away.
They sold Orbital for 5 million US, from what I’ve heard and read it sounds like they’ve given away Aridol and Bronchitol,
They want to focus on being a clinical stage drug development company. They have some great products in the pipeline if they come to fruition, my concern is will they know how to make a profit from the products given their history? Grrrrr
Ann: Investor presentation - quarterly update, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $32.23M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $2.232K | 81.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 280000 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 297894 | 2 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| SNT (ASX) Chart |